GB0101223D0 - Histamine receptor antagonists - Google Patents

Histamine receptor antagonists

Info

Publication number
GB0101223D0
GB0101223D0 GBGB0101223.6A GB0101223A GB0101223D0 GB 0101223 D0 GB0101223 D0 GB 0101223D0 GB 0101223 A GB0101223 A GB 0101223A GB 0101223 D0 GB0101223 D0 GB 0101223D0
Authority
GB
United Kingdom
Prior art keywords
receptor antagonists
histamine receptor
histamine
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0101223.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB0101223.6A priority Critical patent/GB0101223D0/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of GB0101223D0 publication Critical patent/GB0101223D0/en
Priority to KR10-2003-7009493A priority patent/KR20030069216A/ko
Priority to EP02732099A priority patent/EP1353657A1/en
Priority to MXPA03006408A priority patent/MXPA03006408A/es
Priority to IL15608702A priority patent/IL156087A0/xx
Priority to PL02362793A priority patent/PL362793A1/xx
Priority to JP2002557379A priority patent/JP2004517883A/ja
Priority to CA002435121A priority patent/CA2435121A1/en
Priority to CZ20031853A priority patent/CZ20031853A3/cs
Priority to HU0302767A priority patent/HUP0302767A2/hu
Priority to BR0206502-9A priority patent/BR0206502A/pt
Priority to PCT/IB2002/000042 priority patent/WO2002056871A2/en
Priority to EA200300537A priority patent/EA200300537A1/ru
Priority to CNA028036840A priority patent/CN1486178A/zh
Priority to OA1200300174A priority patent/OA12440A/en
Priority to EEP200300335A priority patent/EE200300335A/xx
Priority to SK857-2003A priority patent/SK8572003A3/sk
Priority to DO2002000325A priority patent/DOP2002000325A/es
Priority to PA20028537101A priority patent/PA8537101A1/es
Priority to PE20020000372002000023A priority patent/PE20020822A1/es
Priority to GT200200003A priority patent/GT200200003A/es
Priority to SV2002000849A priority patent/SV2003000849A/es
Priority to TNTNSN02003A priority patent/TNSN02003A1/fr
Priority to ARP020100145A priority patent/AR032101A1/es
Priority to APAP/P/2002/002401A priority patent/AP2002002401A0/en
Priority to US10/052,193 priority patent/US20020132755A1/en
Priority to IS6818A priority patent/IS6818A/is
Priority to BG107834A priority patent/BG107834A/bg
Priority to CR6983A priority patent/CR6983A/es
Priority to ZA200304180A priority patent/ZA200304180B/en
Priority to MA27233A priority patent/MA26980A1/fr
Priority to NO20033223A priority patent/NO20033223L/no
Priority to EC2003004692A priority patent/ECSP034692A/es
Priority to US10/737,619 priority patent/US20040138234A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0101223.6A 2001-01-17 2001-01-17 Histamine receptor antagonists Ceased GB0101223D0 (en)

Priority Applications (34)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists
SK857-2003A SK8572003A3 (en) 2001-01-17 2002-01-10 Histamine receptor antagonists
JP2002557379A JP2004517883A (ja) 2001-01-17 2002-01-10 ヒスタミン受容体アンタゴニスト
CZ20031853A CZ20031853A3 (cs) 2001-01-17 2002-01-10 Antagonisté histaminového receptoru
MXPA03006408A MXPA03006408A (es) 2001-01-17 2002-01-10 Antagonistas de receptores de histamina.
IL15608702A IL156087A0 (en) 2001-01-17 2002-01-10 Histamine receptor antagonists
PL02362793A PL362793A1 (en) 2001-01-17 2002-01-10 Histamine receptor antagonists
KR10-2003-7009493A KR20030069216A (ko) 2001-01-17 2002-01-10 히스타민 수용체 길항제
CA002435121A CA2435121A1 (en) 2001-01-17 2002-01-10 Histamine receptor antagonists
EP02732099A EP1353657A1 (en) 2001-01-17 2002-01-10 Histamine h4 receptor antagonists
HU0302767A HUP0302767A2 (hu) 2001-01-17 2002-01-10 Hisztamin receptor antagonista hatóanyagok
BR0206502-9A BR0206502A (pt) 2001-01-17 2002-01-10 Antagonistas do receptor de histamina
PCT/IB2002/000042 WO2002056871A2 (en) 2001-01-17 2002-01-10 Histamine receptor antagonists
EA200300537A EA200300537A1 (ru) 2001-01-17 2002-01-10 Антагонисты гистаминовых рецепторов
CNA028036840A CN1486178A (zh) 2001-01-17 2002-01-10 组胺受体拮抗剂
OA1200300174A OA12440A (en) 2001-01-17 2002-01-10 Histamine receptor antagonists.
EEP200300335A EE200300335A (et) 2001-01-17 2002-01-10 Histamiiniretseptori antagonistid
DO2002000325A DOP2002000325A (es) 2001-01-17 2002-01-11 Antagonistas de receptores de histamina
PA20028537101A PA8537101A1 (es) 2001-01-17 2002-01-14 Antagonistas de receptores de histamina
PE20020000372002000023A PE20020822A1 (es) 2001-01-17 2002-01-15 Derivados de la urea como antagonistas de integrinantagonistas de receptores de histamina as o4
GT200200003A GT200200003A (es) 2001-01-17 2002-01-16 Antagonistas de receptores de histamina
SV2002000849A SV2003000849A (es) 2001-01-17 2002-01-16 Antagonistas de receptores de histamina ref.pcs10963aksr/bb
TNTNSN02003A TNSN02003A1 (fr) 2001-01-17 2002-01-16 Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant.
ARP020100145A AR032101A1 (es) 2001-01-17 2002-01-16 Antagonistas de receptores de histamina
APAP/P/2002/002401A AP2002002401A0 (en) 2001-01-17 2002-01-17 Histamine receptor antagonists.
US10/052,193 US20020132755A1 (en) 2001-01-17 2002-01-17 Histamine receptor antagonists
IS6818A IS6818A (is) 2001-01-17 2003-05-15 Histamín viðtaka mótlyf
BG107834A BG107834A (bg) 2001-01-17 2003-05-21 Антагонисти на хистаминов рецептор
CR6983A CR6983A (es) 2001-01-17 2003-05-22 Antagonistas de receptores de histamina
ZA200304180A ZA200304180B (en) 2001-01-17 2003-05-29 Histamine receptor antagonists.
MA27233A MA26980A1 (fr) 2001-01-17 2003-07-11 Antagonistes des recepteurs d'histamine.
NO20033223A NO20033223L (no) 2001-01-17 2003-07-16 Histamin-reseptor antagonister
EC2003004692A ECSP034692A (es) 2001-01-17 2003-07-17 Antagonistas de receptores de histamina
US10/737,619 US20040138234A1 (en) 2001-01-17 2003-12-16 Histamine receptor antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
GB0101223D0 true GB0101223D0 (en) 2001-02-28

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0101223.6A Ceased GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Country Status (31)

Country Link
EP (1) EP1353657A1 (es)
JP (1) JP2004517883A (es)
KR (1) KR20030069216A (es)
CN (1) CN1486178A (es)
AP (1) AP2002002401A0 (es)
AR (1) AR032101A1 (es)
BG (1) BG107834A (es)
BR (1) BR0206502A (es)
CA (1) CA2435121A1 (es)
CR (1) CR6983A (es)
CZ (1) CZ20031853A3 (es)
DO (1) DOP2002000325A (es)
EA (1) EA200300537A1 (es)
EC (1) ECSP034692A (es)
EE (1) EE200300335A (es)
GB (1) GB0101223D0 (es)
GT (1) GT200200003A (es)
HU (1) HUP0302767A2 (es)
IL (1) IL156087A0 (es)
IS (1) IS6818A (es)
MA (1) MA26980A1 (es)
MX (1) MXPA03006408A (es)
NO (1) NO20033223L (es)
OA (1) OA12440A (es)
PA (1) PA8537101A1 (es)
PL (1) PL362793A1 (es)
SK (1) SK8572003A3 (es)
SV (1) SV2003000849A (es)
TN (1) TNSN02003A1 (es)
WO (1) WO2002056871A2 (es)
ZA (1) ZA200304180B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
JP2006510590A (ja) * 2002-09-06 2006-03-30 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ アレルギー及び喘息の処置のためのヒスタミンｈ４受容体モジュレーターの使用
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
ES2683380T3 (es) 2012-06-08 2018-09-26 Sensorion Inhibidores del receptor H4 para tratar el tinnitus

Also Published As

Publication number Publication date
AP2002002401A0 (en) 2002-03-31
CN1486178A (zh) 2004-03-31
EE200300335A (et) 2003-12-15
OA12440A (en) 2006-05-22
DOP2002000325A (es) 2003-01-31
NO20033223D0 (no) 2003-07-16
CR6983A (es) 2003-11-25
SK8572003A3 (en) 2004-07-07
EP1353657A1 (en) 2003-10-22
CA2435121A1 (en) 2002-07-25
IS6818A (is) 2003-05-15
JP2004517883A (ja) 2004-06-17
ECSP034692A (es) 2003-08-29
PL362793A1 (en) 2004-11-02
GT200200003A (es) 2002-08-19
SV2003000849A (es) 2003-01-13
KR20030069216A (ko) 2003-08-25
BR0206502A (pt) 2003-10-21
WO2002056871A2 (en) 2002-07-25
HUP0302767A2 (hu) 2003-11-28
EA200300537A1 (ru) 2004-02-26
TNSN02003A1 (fr) 2005-12-23
CZ20031853A3 (cs) 2004-07-14
ZA200304180B (en) 2004-06-15
AR032101A1 (es) 2003-10-22
NO20033223L (no) 2003-07-16
MA26980A1 (fr) 2004-12-20
PA8537101A1 (es) 2002-08-29
IL156087A0 (en) 2003-12-23
BG107834A (bg) 2004-01-30
MXPA03006408A (es) 2003-10-15

Similar Documents

Publication Publication Date Title
EP1351933A4 (en) ANTAGONISTS OF IL-8 RECEPTORS
HK1064100A1 (en) Adenosine a 2a receptor antagonists
AUPR833401A0 (en) G protein-coupled receptor antagonists
IL152775A0 (en) Il-8 receptor antagonists
DZ3309A1 (en) Il-8 receptor antagonists
AU2002365655A1 (en) 5-ht7 receptor antagonists
AU4560601A (en) Il-8 receptor antagonists
EP1359915A4 (en) UROTENSIN-II RECEPTOR ANTAGONISTS
EP1274415A4 (en) IL-8 RECEPTOR ANTAGONISTS
AP2002002599A0 (en) Il-8 receptor antagonists
EP1265905A4 (en) IL-2 RECEPTOR ANTAGONISTS
AU2002359524A8 (en) P2x7 receptor antagonists
EP1274413A4 (en) IL-8 RECEPTOR ANTAGONISTS
GB0101223D0 (en) Histamine receptor antagonists
EP1263427A4 (en) ANTAGONISTS OF THE INTERLEUKIN 8 RECEPTOR
EP1274428A4 (en) INTERLEUKIN-8 (IL-8) RECEPTOR ANTAGONISTS
PL370367A1 (en) Ccr-3 receptor antagonists v
EP1261329A4 (en) IL-8 RECEPTOR ANTAGONISTS
IL158063A0 (en) Crf receptor antagonists
IL151434A0 (en) Il-8 receptor antagonists
AU2002248361A1 (en) Il-8 receptor antagonists
AU2002256981A1 (en) Il-8 receptor antagonists
AU2002338040A1 (en) Receptor antagonist
GB0110662D0 (en) Receptor
GB0111959D0 (en) Receptor

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)